The epithelial cell adhesion molecule (EpCAM) may represent a target for CAR T-cell therapy as EpCAM is overexpressed in about 50% of non-small cell lung cancer and their metastases [11–14]. This evidence concerns the gene EPCAM and non-small cell lung carcinoma.